Literature DB >> 26001755

Elucidation of changes in molecular signalling leading to increased cellular transformation in oncogenically progressed human bronchial epithelial cells exposed to radiations of increasing LET.

Liang-Hao Ding1, Seongmi Park1, Yang Xie2, Luc Girard3, John D Minna4, Michael D Story5.   

Abstract

The early transcriptional response and subsequent induction of anchorage-independent growth after exposure to particles of high Z and energy (HZE) as well as γ-rays were examined in human bronchial epithelial cells (HBEC3KT) immortalised without viral oncogenes and an isogenic variant cell line whose p53 expression was suppressed but that expressed an active mutant K-RAS(V12) (HBEC3KT-P53KRAS). Cell survival following irradiation showed that HBEC3KT-P53KRAS cells were more radioresistant than HBEC3KT cells irrespective of the radiation species. In addition, radiation enhanced the ability of the surviving HBEC3KT-P53RAS cells but not the surviving HBEC3KT cells to grow in anchorage-independent fashion (soft agar colony formation). HZE particle irradiation was far more efficient than γ-rays at rendering HBEC3KT-P53RAS cells permissive for soft agar growth. Gene expression profiles after radiation showed that the molecular response to radiation for HBEC3KT-P53RAS, similar to that for HBEC3KT cells, varies with radiation quality. Several pathways associated with anchorage independent growth, including the HIF-1α, mTOR, IGF-1, RhoA and ERK/MAPK pathways, were over-represented in the irradiated HBEC3KT-P53RAS cells compared to parental HBEC3KT cells. These results suggest that oncogenically progressed human lung epithelial cells are at greater risk for cellular transformation and carcinogenic risk after ionising radiation, but particularly so after HZE radiations. These results have implication for: (i) terrestrial radiation and suggests the possibility of enhanced carcinogenic risk from diagnostic CT screens used for early lung cancer detection; (ii) enhanced carcinogenic risk from heavy particles used in radiotherapy; and (iii) for space radiation, raising the possibility that astronauts harbouring epithelial regions of dysplasia or hyperplasia within the lung that contain oncogenic changes, may have a greater risk for lung cancers based upon their exposure to heavy particles present in the deep space environment.
© The Author 2015. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2015        PMID: 26001755      PMCID: PMC4635632          DOI: 10.1093/mutage/gev028

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  51 in total

1.  Relative biological effectiveness for cell-killing effect on various human cell lines irradiated with heavy-ion medical accelerator in Chiba (HIMAC) carbon-ion beams.

Authors:  M Suzuki; Y Kase; H Yamaguchi; T Kanai; K Ando
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-08-01       Impact factor: 7.038

2.  Induction of lung tumors in RFM mice after localized exposures to X rays or neutrons.

Authors:  R L Ullrich; M C Jernigan; L M Adams
Journal:  Radiat Res       Date:  1979-12       Impact factor: 2.841

3.  Neutron carcinogenesis. Dose and dose-rate effects in BALB/c mice.

Authors:  R L Ullrich; M C Jernigan; J B Storer
Journal:  Radiat Res       Date:  1977-12       Impact factor: 2.841

4.  Mutation and inactivation of mammalian cells by various ionising radiations.

Authors:  R Cox; J Thacker; D T Goodhead; R J Munson
Journal:  Nature       Date:  1977-06-02       Impact factor: 49.962

5.  Malignant transformation in cultured hamster embryo cells produced by X-rays, 460-keV monoenergetic neutrons, and heavy ions.

Authors:  C Borek; E J Hall; H H Rossi
Journal:  Cancer Res       Date:  1978-09       Impact factor: 12.701

6.  Inactivation of human kidney cells by high-energy monoenergetic heavy-ion beams.

Authors:  E A Blakely; C A Tobias; T C Yang; K C Smith; J T Lyman
Journal:  Radiat Res       Date:  1979-10       Impact factor: 2.841

7.  Influence of gamma irradiation on the development of neoplastic disease in mice. III. Dose-rate effects.

Authors:  R L Ullrich; J B Storer
Journal:  Radiat Res       Date:  1979-11       Impact factor: 2.841

8.  Survival, chromosome abnormalities, and recovery in heavy-ion and x-irradiated mammalian cells.

Authors:  L D Skarsgard; B A Kihlman; L Parker; C M Pujara; S Richardson
Journal:  Radiat Res Suppl       Date:  1967

9.  Response of sensitive human ataxia and resistant T-1 cell lines to accelerated heavy ions.

Authors:  C A Tobias; E A Blakely; P Y Chang; L Lommel; R Roots
Journal:  Br J Cancer Suppl       Date:  1984

10.  Tumor induction in BALB/c female mice after fission neutron or gamma irradiation.

Authors:  R L Ullrich
Journal:  Radiat Res       Date:  1983-03       Impact factor: 2.841

View more
  4 in total

Review 1.  Evaluating biomarkers to model cancer risk post cosmic ray exposure.

Authors:  Deepa M Sridharan; Aroumougame Asaithamby; Steve R Blattnig; Sylvain V Costes; Paul W Doetsch; William S Dynan; Philip Hahnfeldt; Lynn Hlatky; Yared Kidane; Amy Kronenberg; Mamta D Naidu; Leif E Peterson; Ianik Plante; Artem L Ponomarev; Janapriya Saha; Antoine M Snijders; Kalayarasan Srinivasan; Jonathan Tang; Erica Werner; Janice M Pluth
Journal:  Life Sci Space Res (Amst)       Date:  2016-05-21

2.  Gene Expression Studies for the Development of Particle Therapy.

Authors:  Sally A Amundson
Journal:  Int J Part Ther       Date:  2018-09-21

3.  Organotypic culture in three dimensions prevents radiation-induced transformation in human lung epithelial cells.

Authors:  Mariam El-Ashmawy; Melissa Coquelin; Krishna Luitel; Kimberly Batten; Jerry W Shay
Journal:  Sci Rep       Date:  2016-08-19       Impact factor: 4.379

4.  Replication stress and FOXM1 drive radiation induced genomic instability and cell transformation.

Authors:  Zhentian Li; David S Yu; Paul W Doetsch; Erica Werner
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.